Medications

J&J faces possible $17 billion payout for pushing opioids

US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.

Medications

Data shows flood of opioids across US, many of them generics

The maker of OxyContin has been cast as the chief villain in the nation's opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose ...

page 36 from 40